ZDA
BMY icon

Zweig-DiMenna Associates’s Bristol-Myers Squibb BMY Stock Holding History

Zweig-DiMenna Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-254,292
Closed -$14.9M – 177
2016
Q4 		$14.9M Buy
254,292
+1,500
+0.6% +$82K 1.07% 28
2016
Q3 		$13.6M Sell
252,792
-46,850
-16% -$3.01M 1.11% 34
2016
Q2 		$22M Sell
299,642
-265,118
-47% -$18.7M 2.25% 10
2016
Q1 		$36.1M Sell
564,760
-335,499
-37% -$21.2M 3.19% 4
2015
Q4 		$61.9M Sell
900,259
-543,464
-38% -$35.9M 3.09% 2
2015
Q3 		$85.5M Buy
1,443,723
+1,433,653
+14,237% +$90.9M 3.7% 3
2015
Q2 		$670K Sell
10,070
-573,872
-98% -$37.8M 0.04% 127
2015
Q1 		$37.7M Buy
+583,942
New +$36.6M 1.58% 10
2013
Q4 		– Sell
-308,272
Closed -$14.3M – 258
2013
Q3 		$14.3M Sell
308,272
-292,398
-49% -$12.8M 0.58% 76
2013
Q2 		$26.8M Buy
+600,670
New +$26.1M 1.08% 17

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zweig-DiMenna Associates's BMY Position: Q1 2017 in Review

Zweig-DiMenna Associates sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 254,292 shares — an estimated $14.9M sold.

Zweig-DiMenna Associates first reported a position in BMY in Q2 2013 and held it in 10 quarters. The position peaked at $85.5M in Q3 2015. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Zweig-DiMenna Associates reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 254,292 Bristol-Myers Squibb shares in Q1 2017, an estimated $14.9M.
  • Zweig-DiMenna Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 10 quarters.
  • Zweig-DiMenna Associates's Bristol-Myers Squibb position peaked at $85.5M in Q3 2015.
  • 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Zweig-DiMenna Associates's 13F filing for Q1 2017, filed 8 May 2017.